ask="4.2000"
ask_size="100"
average_daily_volume="34516"
bid="2.8200"
bid_size="100"
book_value="0.4940"
change="+0.0025"
change_from_200_day_moving_average="-0.0146"
change_from_50_day_moving_average="0.0255"
change_from_52_week_high="-6.2375"
change_From_52_week_low="0.9225"
change_in_percent="+0.0670%"
close="3.7325"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.4210"
ebitda="-15.65M"
eps_estimate_current_year="-1.6200"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-1.4900"
ex_dividend_date="N/A"
float_shares="5720000"
high="3.7400"
high_52_weeks="9.9700"
last_trade_date="1/3/2017"
last_trade_price="3.7325"
last_trade_size="150"
last_trade_time="3:52pm"
low="3.6600"
low_52_weeks="2.8100"
market_capitalization="31.27M"
moving_average_200_day="3.7471"
moving_average_50_day="3.7070"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.5000"
open="3.6620"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-0.3910%"
percent_change_from_50_day_moving_average="+0.6887%"
percent_change_from_52_week_high="-62.5627%"
percent_change_from_52_week_low="+32.8292%"
previous_close="3.7300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.5506"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.6700"
stock_exchange="NCM"
symbol="VTGN"
volume="6084"
weeks_range_52="2.8100 - 9.9700"
